Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Barakat

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Cancer Investigation|December 7, 2000
Should women receiving tamoxifen be screened for endometrial cancer? An argument for screeningA W Menzin, D Gal, R R Barakat
Obstetrics and Gynecology|January 1, 1997
Ovarian and uterine disease in women with colorectal cancerN Abu-Rustum, R R Barakat, J P Curtin
Gynecologic Oncology|May 1, 1995
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervixE A Poynor, R R Barakat, W J Hoskins
Obstetrics and Gynecology|September 1, 1994
Ovarian disease in women with breast cancerJ P Curtin, R R Barakat, W J Hoskins
Acta Cytologica|March 31, 2000
Effects of tamoxifen on cervicovaginal smears from patients with breast cancerM A Abadi, R R Barakat, P E Saigo
Obstetrics and Gynecology|December 1, 1995
Laparoscopic management of adnexal masses in women with a history of nongynecologic malignancyD S Chi, J P Curtin, R R Barakat
Gynecologic Oncology|October 24, 1998
Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimensA Husain, L Aptaker, D R Spriggs, et al.
Gynecologic Oncology|October 1, 1993
Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamatesR R Barakat, W W Li, C Lovelace, et al.
Gynecologic Oncology|July 1, 1997
Hepatic resection for metastatic gynecologic carcinomasD S Chi, Y Fong, E S Venkatraman, et al.
Gynecologic Oncology|November 5, 1997
The role of surgical cytoreduction in Stage IV endometrial carcinomaD S Chi, M Welshinger, E S Venkatraman, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Cancer Investigation|December 7, 2000
Should women receiving tamoxifen be screened for endometrial cancer? An argument for screeningA W Menzin, D Gal, R R Barakat
Obstetrics and Gynecology|January 1, 1997
Ovarian and uterine disease in women with colorectal cancerN Abu-Rustum, R R Barakat, J P Curtin
Gynecologic Oncology|May 1, 1995
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervixE A Poynor, R R Barakat, W J Hoskins
Obstetrics and Gynecology|September 1, 1994
Ovarian disease in women with breast cancerJ P Curtin, R R Barakat, W J Hoskins
Acta Cytologica|March 31, 2000
Effects of tamoxifen on cervicovaginal smears from patients with breast cancerM A Abadi, R R Barakat, P E Saigo
Obstetrics and Gynecology|December 1, 1995
Laparoscopic management of adnexal masses in women with a history of nongynecologic malignancyD S Chi, J P Curtin, R R Barakat
Gynecologic Oncology|October 24, 1998
Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimensA Husain, L Aptaker, D R Spriggs, et al.
Gynecologic Oncology|October 1, 1993
Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamatesR R Barakat, W W Li, C Lovelace, et al.
Gynecologic Oncology|July 1, 1997
Hepatic resection for metastatic gynecologic carcinomasD S Chi, Y Fong, E S Venkatraman, et al.
Gynecologic Oncology|November 5, 1997
The role of surgical cytoreduction in Stage IV endometrial carcinomaD S Chi, M Welshinger, E S Venkatraman, et al.
Pageof 9